Sandoz's Chief Operating Officer Discusses the New Initiative Act4Biosimilars
About This Episode: What is in the future for biosimilars? In this episode, Pierre Bourdage, Chief Operating Officer at Sandoz, lays out the promise and potential of biosimilars, and the important...
31 Elo 202231min
12th Annual DPHARM in Under 10 Minutes
DPHARM Directors, Valerie Bowling and Tracey Kimball, provide a brief overview of what to expect at the 12th annual DPHARM: Disruptive Innovations to Modernize Clinical Research conference. Get 10% o...
6 Elo 202210min
Director's Notes on What to Expect at CRAACO: Clinical Research as a Care Option
In this 9 minute webinar, CRAACO® Conference Producer, Andrew Goldstein is joined by Executive Director, Valerie Bowling where they give a summary on what you can expect at the CRAACO: Clinical Resear...
4 Elo 20229min
What to Expect at Mobile Tech in Clinical Trials 2022
Directors Valerie Bowling and Kate Woda provide a quick overview on what to expect at the 9th annual Mobile Tech in Clinical Trials in under 9 minutes. Get 10% off with code TEML.
2 Elo 20229min
5 Minute Overview Podcast on What to Expect at PODD: Drug Delivery
In this podcast, Valerie Bowling, Director of the PODD: Partnership Opportunities in Drug Delivery conference gives a 5 minute overview on what you can expect at the 12th annual PODD taking place Octo...
19 Heinä 20226min
Key Role of Strategy and Media in Improving Clinical Trial Enrollment Diversity
Summary: Join us for an important discussion about the necessity to adjust and adopt media and research strategies to ensure clinical trial recruitment of diverse populations. PharmaTalkRadio’s Valer...
19 Touko 202218min
How CMOs Can Evaluate Potential Outsourcing Partners Effectively
About the Episode: The number of biotech companies out there makes the struggle to find good talent and good outsourcing partners more difficult and more expensive. As a biotech CMO, working with a C...
2 Touko 202233min
Is the End of SDTM in Sight?
About This Episode: Dr Derk Arts, Founder and CEO of Castor, lays out what he views as the next phase of data presentation to regulatory agencies, moving away from the standard SDTM (study data tabu...
2 Touko 202224min
